APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pan-cancer Genomic Profiling

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pan-cancer Genomic Profiling Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174522040312 August 2026198 pages

Choose your research edition.

Industry ResearchPan-cancer Genomic Profiling Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Pan-cancer Genomic Profiling Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Pan-cancer Genomic Profiling Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pan-cancer Genomic Profiling Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Pan-cancer Genomic Profiling Market Analysis and Forecast 2026-2032181 pages · $4,950 USD

Market perspective

The global Pan-cancer Genomic Profiling market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Pan-cancer Genomic Profiling is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pan-cancer Genomic Profiling is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pan-cancer Genomic Profiling is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pan-cancer Genomic Profiling is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pan-cancer Genomic Profiling include Tempus AI, Labcorp, NeoGenomics, Exact Sciences, Personalis, Illumina, Thermo Fisher Scientific, QIAGEN and Agilent Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Pan-cancer Genomic Profiling market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pan-cancer Genomic Profiling and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pan-cancer Genomic Profiling revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pan-cancer Genomic Profiling market size, projected growth trends, production technologies, key applications, and end-use industries.

Pan-cancer Genomic Profiling Segment by Company

Tempus AI

Labcorp

NeoGenomics

Exact Sciences

Personalis

Illumina

Thermo Fisher Scientific

QIAGEN

Agilent Technologies

SOPHiA GENETICS

Sysmex

Burning Rock Biotech

Genetron Health

Geneseeq

BGI Genomics

Amoy Diagnostics

Roche

Guardant Health

Caris Life Sciences

Pan-cancer Genomic Profiling Segment by Type

Tissue-based Profiling

Liquid Biopsy Profiling

Other

Pan-cancer Genomic Profiling Segment by Application

Hospitals and Cancer Centers

Independent Clinical Laboratories

Pharmaceutical and Biotechnology Companies

Other

Pan-cancer Genomic Profiling Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pan-cancer Genomic Profiling market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pan-cancer Genomic Profiling and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pan-cancer Genomic Profiling.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pan-cancer Genomic Profiling in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pan-cancer Genomic Profiling industry.

Chapter 3: Detailed analysis of Pan-cancer Genomic Profiling companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pan-cancer Genomic Profilingrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pan-cancer Genomic Profiling Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Tissue-based Profiling Table 3. Key Players of Liquid Biopsy Profiling Table 4. Key Players of Other Table 4. Global Pan-cancer Genomic Profiling Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospitals and Cancer Centers Table 6. Key Players of Independent Clinical Laboratories Table 7. Key Players of Pharmaceutical and Biotechnology Companies Table 8. Key Players of Other Table 9. Global Pan-cancer Genomic Profiling Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Pan-cancer Genomic Profiling Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Pan-cancer Genomic Profiling Market Share by Region (2021-2026) Table 12. Global Pan-cancer Genomic Profiling Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Pan-cancer Genomic Profiling Market Share by Region (2027-2032) Table 14. Pan-cancer Genomic Profiling Industry Trends Table 15. Pan-cancer Genomic Profiling Industry Drivers Table 16. Pan-cancer Genomic Profiling Industry Opportunities and Challenges Table 17. Pan-cancer Genomic Profiling Industry Restraints Table 18. Global Pan-cancer Genomic Profiling Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Pan-cancer Genomic Profiling Revenue Market Share by Company (2021-2026) Table 20. Global Pan-cancer Genomic Profiling Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Pan-cancer Genomic Profiling Key Company Head Office and Area Served Table 22. Global Pan-cancer Genomic Profiling Company, Product Type & Application Table 23. Global Pan-cancer Genomic Profiling Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Pan-cancer Genomic Profiling by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Pan-cancer Genomic Profiling Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pan-cancer Genomic Profiling Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Pan-cancer Genomic Profiling Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Pan-cancer Genomic Profiling Revenue Market Share by Type (2021-2026) Table 30. Global Pan-cancer Genomic Profiling Revenue Market Share by Type (2027-2032) Table 31. Global Pan-cancer Genomic Profiling Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pan-cancer Genomic Profiling Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Pan-cancer Genomic Profiling Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Pan-cancer Genomic Profiling Revenue Market Share by Application (2021-2026) Table 35. Global Pan-cancer Genomic Profiling Revenue Market Share by Application (2027-2032) Table 36. Tempus AI Company Information Table 37. Tempus AI Business Overview Table 38. Tempus AI Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Tempus AI Pan-cancer Genomic Profiling Product Portfolio Table 40. Tempus AI Recent Development Table 41. Labcorp Company Information Table 42. Labcorp Business Overview Table 43. Labcorp Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Labcorp Pan-cancer Genomic Profiling Product Portfolio Table 45. Labcorp Recent Development Table 46. NeoGenomics Company Information Table 47. NeoGenomics Business Overview Table 48. NeoGenomics Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. NeoGenomics Pan-cancer Genomic Profiling Product Portfolio Table 50. NeoGenomics Recent Development Table 51. Exact Sciences Company Information Table 52. Exact Sciences Business Overview Table 53. Exact Sciences Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Exact Sciences Pan-cancer Genomic Profiling Product Portfolio Table 55. Exact Sciences Recent Development Table 56. Personalis Company Information Table 57. Personalis Business Overview Table 58. Personalis Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Personalis Pan-cancer Genomic Profiling Product Portfolio Table 60. Personalis Recent Development Table 61. Illumina Company Information Table 62. Illumina Business Overview Table 63. Illumina Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Illumina Pan-cancer Genomic Profiling Product Portfolio Table 65. Illumina Recent Development Table 66. Thermo Fisher Scientific Company Information Table 67. Thermo Fisher Scientific Business Overview Table 68. Thermo Fisher Scientific Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Thermo Fisher Scientific Pan-cancer Genomic Profiling Product Portfolio Table 70. Thermo Fisher Scientific Recent Development Table 71. QIAGEN Company Information Table 72. QIAGEN Business Overview Table 73. QIAGEN Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. QIAGEN Pan-cancer Genomic Profiling Product Portfolio Table 75. QIAGEN Recent Development Table 76. Agilent Technologies Company Information Table 77. Agilent Technologies Business Overview Table 78. Agilent Technologies Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Agilent Technologies Pan-cancer Genomic Profiling Product Portfolio Table 80. Agilent Technologies Recent Development Table 81. SOPHiA GENETICS Company Information Table 82. SOPHiA GENETICS Business Overview Table 83. SOPHiA GENETICS Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. SOPHiA GENETICS Pan-cancer Genomic Profiling Product Portfolio Table 85. SOPHiA GENETICS Recent Development Table 86. Sysmex Company Information Table 87. Sysmex Business Overview Table 88. Sysmex Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Sysmex Pan-cancer Genomic Profiling Product Portfolio Table 90. Sysmex Recent Development Table 91. Burning Rock Biotech Company Information Table 92. Burning Rock Biotech Business Overview Table 93. Burning Rock Biotech Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Burning Rock Biotech Pan-cancer Genomic Profiling Product Portfolio Table 95. Burning Rock Biotech Recent Development Table 96. Genetron Health Company Information Table 97. Genetron Health Business Overview Table 98. Genetron Health Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Genetron Health Pan-cancer Genomic Profiling Product Portfolio Table 100. Genetron Health Recent Development Table 101. Geneseeq Company Information Table 102. Geneseeq Business Overview Table 103. Geneseeq Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. Geneseeq Pan-cancer Genomic Profiling Product Portfolio Table 105. Geneseeq Recent Development Table 106. BGI Genomics Company Information Table 107. BGI Genomics Business Overview Table 108. BGI Genomics Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. BGI Genomics Pan-cancer Genomic Profiling Product Portfolio Table 110. BGI Genomics Recent Development Table 111. Amoy Diagnostics Company Information Table 112. Amoy Diagnostics Business Overview Table 113. Amoy Diagnostics Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. Amoy Diagnostics Pan-cancer Genomic Profiling Product Portfolio Table 115. Amoy Diagnostics Recent Development Table 116. Roche Company Information Table 117. Roche Business Overview Table 118. Roche Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026) Table 119. Roche Pan-cancer Genomic Profiling Product Portfolio Table 120. Roche Recent Development Table 121. Guardant Health Company Information Table 122. Guardant Health Business Overview Table 123. Guardant Health Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026) Table 124. Guardant Health Pan-cancer Genomic Profiling Product Portfolio Table 125. Guardant Health Recent Development Table 126. Caris Life Sciences Company Information Table 127. Caris Life Sciences Business Overview Table 128. Caris Life Sciences Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026) Table 129. Caris Life Sciences Pan-cancer Genomic Profiling Product Portfolio Table 130. Caris Life Sciences Recent Development Table 131. North America Pan-cancer Genomic Profiling Market Size by Type (2021-2026) & (US$ Million) Table 132. North America Pan-cancer Genomic Profiling Market Size by Type (2027-2032) & (US$ Million) Table 133. North America Pan-cancer Genomic Profiling Market Size by Application (2021-2026) & (US$ Million) Table 134. North America Pan-cancer Genomic Profiling Market Size by Application (2027-2032) & (US$ Million) Table 135. North America Pan-cancer Genomic Profiling Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. North America Pan-cancer Genomic Profiling Market Size by Country (2021-2026) Table 137. North America Pan-cancer Genomic Profiling Market Size by Country (2027-2032) Table 138. Europe Pan-cancer Genomic Profiling Market Size by Type (2021-2026) & (US$ Million) Table 139. Europe Pan-cancer Genomic Profiling Market Size by Type (2027-2032) & (US$ Million) Table 140. Europe Pan-cancer Genomic Profiling Market Size by Application (2021-2026) & (US$ Million) Table 141. Europe Pan-cancer Genomic Profiling Market Size by Application (2027-2032) & (US$ Million) Table 142. Europe Pan-cancer Genomic Profiling Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Europe Pan-cancer Genomic Profiling Market Size by Country (2021-2026) Table 144. Europe Pan-cancer Genomic Profiling Market Size by Country (2027-2032) Table 145. China Pan-cancer Genomic Profiling Market Size by Type (2021-2026) & (US$ Million) Table 146. China Pan-cancer Genomic Profiling Market Size by Type (2027-2032) & (US$ Million) Table 147. China Pan-cancer Genomic Profiling Market Size by Application (2021-2026) & (US$ Million) Table 148. China Pan-cancer Genomic Profiling Market Size by Application (2027-2032) & (US$ Million) Table 149. Asia Pan-cancer Genomic Profiling Market Size by Type (2021-2026) & (US$ Million) Table 150. Asia Pan-cancer Genomic Profiling Market Size by Type (2027-2032) & (US$ Million) Table 151. Asia Pan-cancer Genomic Profiling Market Size by Application (2021-2026) & (US$ Million) Table 152. Asia Pan-cancer Genomic Profiling Market Size by Application (2027-2032) & (US$ Million) Table 153. Asia Pan-cancer Genomic Profiling Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. Asia Pan-cancer Genomic Profiling Market Size by Country (2021-2026) Table 155. Asia Pan-cancer Genomic Profiling Market Size by Country (2027-2032) Table 156. South America, Middle East & Africa Pan-cancer Genomic Profiling Market Size by Type (2021-2026) & (US$ Million) Table 157. South America, Middle East & Africa Pan-cancer Genomic Profiling Market Size by Type (2027-2032) & (US$ Million) Table 158. South America, Middle East & Africa Pan-cancer Genomic Profiling Market Size by Application (2021-2026) & (US$ Million) Table 159. South America, Middle East & Africa Pan-cancer Genomic Profiling Market Size by Application (2027-2032) & (US$ Million) Table 160. South America, Middle East & Africa Pan-cancer Genomic Profiling Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 161. South America, Middle East & Africa Pan-cancer Genomic Profiling Market Size by Country (2021-2026) Table 162. South America, Middle East & Africa Pan-cancer Genomic Profiling Market Size by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. Pan-cancer Genomic Profiling Product Image Figure 2. Global Pan-cancer Genomic Profiling Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Pan-cancer Genomic Profiling Market Share by Type: 2025 VS 2032 Figure 4. Tissue-based Profiling Image Figure 5. Liquid Biopsy Profiling Image Figure 6. Other Image Figure 7. Global Pan-cancer Genomic Profiling Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Pan-cancer Genomic Profiling Market Share by Application: 2025 VS 2032 Figure 9. Hospitals and Cancer Centers Image Figure 10. Independent Clinical Laboratories Image Figure 11. Pharmaceutical and Biotechnology Companies Image Figure 12. Other Image Figure 13. Global Pan-cancer Genomic Profiling Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Pan-cancer Genomic Profiling Market Size (2021-2032) & (US$ Million) Figure 15. Global Pan-cancer Genomic Profiling Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Pan-cancer Genomic Profiling Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Pan-cancer Genomic Profiling Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Pan-cancer Genomic Profiling Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Pan-cancer Genomic Profiling Revenue Market Share by Type (2021-2032) Figure 22. Global Pan-cancer Genomic Profiling Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Pan-cancer Genomic Profiling Revenue Market Share by Application (2021-2032) Figure 24. North America Pan-cancer Genomic Profiling Market Size (2021-2032) & (US$ Million) Figure 25. North America Pan-cancer Genomic Profiling Market Share by Type (2021-2032) Figure 26. North America Pan-cancer Genomic Profiling Market Share by Application (2021-2032) Figure 27. North America Pan-cancer Genomic Profiling Market Share by Country (2021-2032) Figure 28. United States Pan-cancer Genomic Profiling Market Size (2021-2032) & (US$ Million) Figure 29. Canada Pan-cancer Genomic Profiling Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Pan-cancer Genomic Profiling Market Size (2021-2032) & (US$ Million) Figure 31. Europe Pan-cancer Genomic Profiling Market Size (2021-2032) & (US$ Million) Figure 32. Europe Pan-cancer Genomic Profiling Market Share by Type (2021-2032) Figure 33. Europe Pan-cancer Genomic Profiling Market Share by Application (2021-2032) Figure 34. Europe Pan-cancer Genomic Profiling Market Share by Country (2021-2032) Figure 35. Germany Pan-cancer Genomic Profiling Market Size (2021-2032) & (US$ Million) Figure 36. France Pan-cancer Genomic Profiling Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Pan-cancer Genomic Profiling Market Size (2021-2032) & (US$ Million) Figure 38. Italy Pan-cancer Genomic Profiling Market Size (2021-2032) & (US$ Million) Figure 39. Russia Pan-cancer Genomic Profiling Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Pan-cancer Genomic Profiling Market Size (2021-2032) & (US$ Million) Figure 41. China Pan-cancer Genomic Profiling Market Size (2021-2032) & (US$ Million) Figure 42. China Pan-cancer Genomic Profiling Market Share by Type (2021-2032) Figure 43. China Pan-cancer Genomic Profiling Market Share by Application (2021-2032) Figure 44. Asia Pan-cancer Genomic Profiling Market Size (2021-2032) & (US$ Million) Figure 45. Asia Pan-cancer Genomic Profiling Market Share by Type (2021-2032) Figure 46. Asia Pan-cancer Genomic Profiling Market Share by Application (2021-2032) Figure 47. Asia Pan-cancer Genomic Profiling Market Share by Country (2021-2032) Figure 48. Japan Pan-cancer Genomic Profiling Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Pan-cancer Genomic Profiling Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Pan-cancer Genomic Profiling Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Pan-cancer Genomic Profiling Market Size (2021-2032) & (US$ Million) Figure 52. India Pan-cancer Genomic Profiling Market Size (2021-2032) & (US$ Million) Figure 53. Australia Pan-cancer Genomic Profiling Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Pan-cancer Genomic Profiling Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Pan-cancer Genomic Profiling Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Pan-cancer Genomic Profiling Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Pan-cancer Genomic Profiling Market Share by Country (2021-2032) Figure 58. Brazil Pan-cancer Genomic Profiling Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Pan-cancer Genomic Profiling Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Pan-cancer Genomic Profiling Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Pan-cancer Genomic Profiling Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Pan-cancer Genomic Profiling Market Size (2021-2032) & (US$ Million) Figure 63. UAE Pan-cancer Genomic Profiling Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Pan-cancer Genomic Profiling Market Size (2021-2032) & (US$ Million) Figure 65. Chile Pan-cancer Genomic Profiling Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Tissue-based Profiling
  • Liquid Biopsy Profiling
  • Other
Applications
  • Hospitals and Cancer Centers
  • Independent Clinical Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Other
Companies covered
  • Tempus AI
  • Labcorp
  • NeoGenomics
  • Exact Sciences
  • Personalis
  • Illumina
  • Thermo Fisher Scientific
  • QIAGEN
  • Agilent Technologies
  • SOPHiA GENETICS
  • Sysmex
  • Burning Rock Biotech
  • Genetron Health
  • Geneseeq
  • BGI Genomics
  • Amoy Diagnostics
  • Roche
  • Guardant Health
  • Caris Life Sciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Pan-cancer Genomic Profiling Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Tissue-based Profiling
  5. 1.2.3 Liquid Biopsy Profiling
  6. 1.2.4 Other
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Pan-cancer Genomic Profiling Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Hospitals and Cancer Centers
  10. 1.3.3 Independent Clinical Laboratories
  11. 1.3.4 Pharmaceutical and Biotechnology Companies
  12. 1.3.5 Other
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Pan-cancer Genomic Profiling Growth Trends by Region
  15. 1.5.1 Global Pan-cancer Genomic Profiling Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Pan-cancer Genomic Profiling Market Size by Region (2021-2026)
  17. 1.5.3 Pan-cancer Genomic Profiling Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Pan-cancer Genomic Profiling Market Dynamics
  1. 2.1 Pan-cancer Genomic Profiling Industry Trends
  2. 2.2 Pan-cancer Genomic Profiling Industry Drivers
  3. 2.3 Pan-cancer Genomic Profiling Industry Opportunities and Challenges
  4. 2.4 Pan-cancer Genomic Profiling Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Pan-cancer Genomic Profiling Revenue by Company (2021-2026)
  2. 3.2 Global Pan-cancer Genomic Profiling Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Pan-cancer Genomic Profiling Key Company Head office and Area Served
  4. 3.4 Global Pan-cancer Genomic Profiling Company, Product Type & Application
  5. 3.5 Global Pan-cancer Genomic Profiling Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Pan-cancer Genomic Profiling Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Pan-cancer Genomic Profiling Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Pan-cancer Genomic Profiling Tier 1, Tier 2, and Tier 3
4 Pan-cancer Genomic Profiling Market by Type
  1. 4.1 Global Pan-cancer Genomic Profiling Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Pan-cancer Genomic Profiling Market Size by Type (2021-2032)
  3. 4.3 Global Pan-cancer Genomic Profiling Market Size Share by Type (2021-2032)
5 Pan-cancer Genomic Profiling Market by Application
  1. 5.1 Global Pan-cancer Genomic Profiling Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Pan-cancer Genomic Profiling Market Size by Application (2021-2032)
  3. 5.3 Global Pan-cancer Genomic Profiling Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Tempus AI
  2. 6.1.1 Tempus AI Company Information
  3. 6.1.2 Tempus AI Business Overview
  4. 6.1.3 Tempus AI Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Tempus AI Pan-cancer Genomic Profiling Product Portfolio
  6. 6.1.5 Tempus AI Recent Developments
  7. 6.2 Labcorp
  8. 6.2.1 Labcorp Company Information
  9. 6.2.2 Labcorp Business Overview
  10. 6.2.3 Labcorp Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Labcorp Pan-cancer Genomic Profiling Product Portfolio
  12. 6.2.5 Labcorp Recent Developments
  13. 6.3 NeoGenomics
  14. 6.3.1 NeoGenomics Company Information
  15. 6.3.2 NeoGenomics Business Overview
  16. 6.3.3 NeoGenomics Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 NeoGenomics Pan-cancer Genomic Profiling Product Portfolio
  18. 6.3.5 NeoGenomics Recent Developments
  19. 6.4 Exact Sciences
  20. 6.4.1 Exact Sciences Company Information
  21. 6.4.2 Exact Sciences Business Overview
  22. 6.4.3 Exact Sciences Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Exact Sciences Pan-cancer Genomic Profiling Product Portfolio
  24. 6.4.5 Exact Sciences Recent Developments
  25. 6.5 Personalis
  26. 6.5.1 Personalis Company Information
  27. 6.5.2 Personalis Business Overview
  28. 6.5.3 Personalis Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Personalis Pan-cancer Genomic Profiling Product Portfolio
  30. 6.5.5 Personalis Recent Developments
  31. 6.6 Illumina
  32. 6.6.1 Illumina Company Information
  33. 6.6.2 Illumina Business Overview
  34. 6.6.3 Illumina Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Illumina Pan-cancer Genomic Profiling Product Portfolio
  36. 6.6.5 Illumina Recent Developments
  37. 6.7 Thermo Fisher Scientific
  38. 6.7.1 Thermo Fisher Scientific Company Information
  39. 6.7.2 Thermo Fisher Scientific Business Overview
  40. 6.7.3 Thermo Fisher Scientific Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Thermo Fisher Scientific Pan-cancer Genomic Profiling Product Portfolio
  42. 6.7.5 Thermo Fisher Scientific Recent Developments
  43. 6.8 QIAGEN
  44. 6.8.1 QIAGEN Company Information
  45. 6.8.2 QIAGEN Business Overview
  46. 6.8.3 QIAGEN Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 QIAGEN Pan-cancer Genomic Profiling Product Portfolio
  48. 6.8.5 QIAGEN Recent Developments
  49. 6.9 Agilent Technologies
  50. 6.9.1 Agilent Technologies Company Information
  51. 6.9.2 Agilent Technologies Business Overview
  52. 6.9.3 Agilent Technologies Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Agilent Technologies Pan-cancer Genomic Profiling Product Portfolio
  54. 6.9.5 Agilent Technologies Recent Developments
  55. 6.10 SOPHiA GENETICS
  56. 6.10.1 SOPHiA GENETICS Company Information
  57. 6.10.2 SOPHiA GENETICS Business Overview
  58. 6.10.3 SOPHiA GENETICS Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 SOPHiA GENETICS Pan-cancer Genomic Profiling Product Portfolio
  60. 6.10.5 SOPHiA GENETICS Recent Developments
  61. 6.11 Sysmex
  62. 6.11.1 Sysmex Company Information
  63. 6.11.2 Sysmex Business Overview
  64. 6.11.3 Sysmex Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Sysmex Pan-cancer Genomic Profiling Product Portfolio
  66. 6.11.5 Sysmex Recent Developments
  67. 6.12 Burning Rock Biotech
  68. 6.12.1 Burning Rock Biotech Company Information
  69. 6.12.2 Burning Rock Biotech Business Overview
  70. 6.12.3 Burning Rock Biotech Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Burning Rock Biotech Pan-cancer Genomic Profiling Product Portfolio
  72. 6.12.5 Burning Rock Biotech Recent Developments
  73. 6.13 Genetron Health
  74. 6.13.1 Genetron Health Company Information
  75. 6.13.2 Genetron Health Business Overview
  76. 6.13.3 Genetron Health Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Genetron Health Pan-cancer Genomic Profiling Product Portfolio
  78. 6.13.5 Genetron Health Recent Developments
  79. 6.14 Geneseeq
  80. 6.14.1 Geneseeq Company Information
  81. 6.14.2 Geneseeq Business Overview
  82. 6.14.3 Geneseeq Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Geneseeq Pan-cancer Genomic Profiling Product Portfolio
  84. 6.14.5 Geneseeq Recent Developments
  85. 6.15 BGI Genomics
  86. 6.15.1 BGI Genomics Company Information
  87. 6.15.2 BGI Genomics Business Overview
  88. 6.15.3 BGI Genomics Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 BGI Genomics Pan-cancer Genomic Profiling Product Portfolio
  90. 6.15.5 BGI Genomics Recent Developments
  91. 6.16 Amoy Diagnostics
  92. 6.16.1 Amoy Diagnostics Company Information
  93. 6.16.2 Amoy Diagnostics Business Overview
  94. 6.16.3 Amoy Diagnostics Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Amoy Diagnostics Pan-cancer Genomic Profiling Product Portfolio
  96. 6.16.5 Amoy Diagnostics Recent Developments
  97. 6.17 Roche
  98. 6.17.1 Roche Company Information
  99. 6.17.2 Roche Business Overview
  100. 6.17.3 Roche Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Roche Pan-cancer Genomic Profiling Product Portfolio
  102. 6.17.5 Roche Recent Developments
  103. 6.18 Guardant Health
  104. 6.18.1 Guardant Health Company Information
  105. 6.18.2 Guardant Health Business Overview
  106. 6.18.3 Guardant Health Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Guardant Health Pan-cancer Genomic Profiling Product Portfolio
  108. 6.18.5 Guardant Health Recent Developments
  109. 6.19 Caris Life Sciences
  110. 6.19.1 Caris Life Sciences Company Information
  111. 6.19.2 Caris Life Sciences Business Overview
  112. 6.19.3 Caris Life Sciences Pan-cancer Genomic Profiling Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Caris Life Sciences Pan-cancer Genomic Profiling Product Portfolio
  114. 6.19.5 Caris Life Sciences Recent Developments
7 North America
  1. 7.1 North America Pan-cancer Genomic Profiling Market Size (2021-2032)
  2. 7.2 North America Pan-cancer Genomic Profiling Market Size by Type
  3. 7.2.1 North America Pan-cancer Genomic Profiling Market Size by Type (2021-2026)
  4. 7.2.2 North America Pan-cancer Genomic Profiling Market Size by Type (2027-2032)
  5. 7.2.3 North America Pan-cancer Genomic Profiling Market Share by Type (2021-2032)
  6. 7.3 North America Pan-cancer Genomic Profiling Market Size by Application
  7. 7.3.1 North America Pan-cancer Genomic Profiling Market Size by Application (2021-2026)
  8. 7.3.2 North America Pan-cancer Genomic Profiling Market Size by Application (2027-2032)
  9. 7.3.3 North America Pan-cancer Genomic Profiling Market Share by Application (2021-2032)
  10. 7.4 North America Pan-cancer Genomic Profiling Market Size by Country
  11. 7.4.1 North America Pan-cancer Genomic Profiling Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Pan-cancer Genomic Profiling Market Size by Country (2021-2026)
  13. 7.4.3 North America Pan-cancer Genomic Profiling Market Size by Country (2027-2032)
  14. 7.4.4 North America Pan-cancer Genomic Profiling Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Pan-cancer Genomic Profiling Market Size (2021-2032)
  2. 8.2 Europe Pan-cancer Genomic Profiling Market Size by Type
  3. 8.2.1 Europe Pan-cancer Genomic Profiling Market Size by Type (2021-2026)
  4. 8.2.2 Europe Pan-cancer Genomic Profiling Market Size by Type (2027-2032)
  5. 8.2.3 Europe Pan-cancer Genomic Profiling Market Share by Type (2021-2032)
  6. 8.3 Europe Pan-cancer Genomic Profiling Market Size by Application
  7. 8.3.1 Europe Pan-cancer Genomic Profiling Market Size by Application (2021-2026)
  8. 8.3.2 Europe Pan-cancer Genomic Profiling Market Size by Application (2027-2032)
  9. 8.3.3 Europe Pan-cancer Genomic Profiling Market Share by Application (2021-2032)
  10. 8.4 Europe Pan-cancer Genomic Profiling Market Size by Country
  11. 8.4.1 Europe Pan-cancer Genomic Profiling Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Pan-cancer Genomic Profiling Market Size by Country (2021-2026)
  13. 8.4.3 Europe Pan-cancer Genomic Profiling Market Size by Country (2027-2032)
  14. 8.4.4 Europe Pan-cancer Genomic Profiling Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Pan-cancer Genomic Profiling Market Size (2021-2032)
  2. 9.2 China Pan-cancer Genomic Profiling Market Size by Type
  3. 9.2.1 China Pan-cancer Genomic Profiling Market Size by Type (2021-2026)
  4. 9.2.2 China Pan-cancer Genomic Profiling Market Size by Type (2027-2032)
  5. 9.2.3 China Pan-cancer Genomic Profiling Market Share by Type (2021-2032)
  6. 9.3 China Pan-cancer Genomic Profiling Market Size by Application
  7. 9.3.1 China Pan-cancer Genomic Profiling Market Size by Application (2021-2026)
  8. 9.3.2 China Pan-cancer Genomic Profiling Market Size by Application (2027-2032)
  9. 9.3.3 China Pan-cancer Genomic Profiling Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Pan-cancer Genomic Profiling Market Size (2021-2032)
  2. 10.2 Asia Pan-cancer Genomic Profiling Market Size by Type
  3. 10.2.1 Asia Pan-cancer Genomic Profiling Market Size by Type (2021-2026)
  4. 10.2.2 Asia Pan-cancer Genomic Profiling Market Size by Type (2027-2032)
  5. 10.2.3 Asia Pan-cancer Genomic Profiling Market Share by Type (2021-2032)
  6. 10.3 Asia Pan-cancer Genomic Profiling Market Size by Application
  7. 10.3.1 Asia Pan-cancer Genomic Profiling Market Size by Application (2021-2026)
  8. 10.3.2 Asia Pan-cancer Genomic Profiling Market Size by Application (2027-2032)
  9. 10.3.3 Asia Pan-cancer Genomic Profiling Market Share by Application (2021-2032)
  10. 10.4 Asia Pan-cancer Genomic Profiling Market Size by Country
  11. 10.4.1 Asia Pan-cancer Genomic Profiling Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Pan-cancer Genomic Profiling Market Size by Country (2021-2026)
  13. 10.4.3 Asia Pan-cancer Genomic Profiling Market Size by Country (2027-2032)
  14. 10.4.4 Asia Pan-cancer Genomic Profiling Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Pan-cancer Genomic Profiling Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Pan-cancer Genomic Profiling Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Pan-cancer Genomic Profiling Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Pan-cancer Genomic Profiling Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Pan-cancer Genomic Profiling Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Pan-cancer Genomic Profiling Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Pan-cancer Genomic Profiling Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Pan-cancer Genomic Profiling Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Pan-cancer Genomic Profiling Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Pan-cancer Genomic Profiling Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Pan-cancer Genomic Profiling Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Pan-cancer Genomic Profiling Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Pan-cancer Genomic Profiling Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Pan-cancer Genomic Profiling Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst